FDA Investigator Mary C Wall
Mary C Wall has inspections in 1 countries as of 14 Mar 2024. Mary C Wall has collaborated with a combined 2320 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
48
Last Inspection Date:
14 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alex G Kalugin,
Alexandra B Pitkin,
Alexis R Ajello,
Alice A Blair,
Alla Dubrovsky,
Andrea J Schmidt,
Andrew Tadros,
Andrews,
Angel K Sandhu,
Angela D Wise,
Anna L Marroquin,
Anna L Viveros Hernandez,
Aryonna M Renouf,
Ashar P Parikh,
Ashley J Allen Gaines,
Breena L D'ambrogi,
Brian Ravitch,
Bryce A May,
Carl Lee,
Carr,
Cesar A Herrera,
Chan,
Christine M Parmentier,
Christopher J Lee,
Cori W Bitterman,
Courtney R Bolton,
Courtney R Warren,
Daniel J Roberts,
David A Laplante,
David G Whitman,
David J Leray,
Davis,
Deborah K Richardson,
Debra L Curtis,
Dejon N Harris,
Dena L Jacobs,
Derek S Dealy,
Diana M Rand,
Edna J Hidalgo,
Elizabeth P Mayer,
Elodie Xtong Lin,
Elva M Ibarra,
Emmanuel O Kerry,
Erica R Havely,
Erica R Pomeroy,
Felicia M Orlando,
Francisco,
Garrad R Poole,
Gary L Hartman,
Geoffrey M Leist,
Gillenwater,
Helen J Hamaoka,
Hoover,
Irdee W Wilson,
Ismael Garibay,
Jacob W Reynolds,
James C Lee, PharmD,
James P Stallings,
Jamie L Port,
Jane G Choi,
Janice Wai,
Jazmine M Welcher,
Jeanne A Young,
Jennifer L Johnson,
Jennifer M Pouget,
Jennifer S King,
Joan T Briones,
Jocelyn T Ramos,
John A Daubenspeck,
John A Liu,
John Cheung,
Jorge L Bertran,
Joseph M Willems,
Joseph Tibay,
Juan A Morales,
Judy C Nepsa,
Juliane Kjung Lau,
Karen D Phung,
Karen J Bak,
Karen M Willis,
Karla J Gibler,
Kawshalya Pathiraja,
Keith C Littrell,
Kelvin X Sanders,
Kevin P Foley,
Kevin T Gerrity,
Kin T Moy,
Larkin R Buckalew,
Larry Gehring,
Laura A Munsterman,
Laura L Van Wagenen,
Lee,
Leongc,
Linda S Shook,
Lisa H Nakagawa,
Mabel M Lee,
Macropolk,
Maida Henesian (NMI),
Marco A Solorio,
Marcus F Yambot,
Maridali De Leon Torres,
Mark I Nakano,
Mary C Acton,
Mary F Bodick,
Mcgrewp,
Michelle J Hines,
Michelle L Tripp,
Nicholas Fragedakis,
Patricia P Wrona,
Patrick E Gainer,
Phillip J Sample,
Phung,
Quynh H Strandberg,
Riley C Graham,
Rochelle A Rolnik,
Rocio Guzman Velazquez,
Roger D Gawne,
Romero,
Rumany C Penn, PharmD,
Sandra K Masters,
Sandra S Saniga,
Sara Jdent Acosta,
Savannah E Samp,
Shaquenta Y Perkins,
Sharon L Shane,
Sheila Alaghemand,
Shererk,
Sparky L Bartee,
State Agency,
Steven C Himebaugh,
Stuart W Russell,
Sundy Ven,
Thanh M Andrews,
Thomas N Adjabeng,
Timothy T Kapsala,
Tomanik'e C Banks,
Travelle D Mason,
Victoria L Morgan,
Victoria Taylor,
William J Weis,
William V Millar,
Yen Tso Kuo
Mary C Wall's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2023 | FDA 483 | Sol-ti Inc. - Form 483, 2023-02-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more